Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA5A | P35218 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | ACP3 | P15309 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18243713 | 0.93 | NFKB1 (0.36) | ELANENFKB1CA1CA2 | |
| SCHEMBL2096273 | 0.86 | NFKB1 (0.35) | ELANENFKB1CA1CA2CA5A | |
| SCHEMBL28256785 | 0.83 | ELANE (0.36) | ELANENFKB1CA1CA2CA5A | |
| SCHEMBL2185812 | 0.82 | NFKB1 (0.33) | NFKB1CA1CA2CA5ACA9 | |
| SCHEMBL18243059 | 0.79 | ELANE (0.35) | ELANELMNA | |
| SCHEMBL18243901 | 0.79 | CES1 (0.33) | ELANE | |
| SCHEMBL18378333 | 0.78 | ELANE (0.34) | ELANE | |
| SCHEMBL8630737 | 0.76 | NFKB1 (0.35) | NFKB1CA1CA2CA5ACA9 | |
| SCHEMBL8846995 | 0.75 | MAPT (0.35) | ELANENFKB1CA1CA2CA5A | |
| SCHEMBL187641 | 0.75 | NFKB1 (0.47) | NFKB1LMNAGAAACP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10862169-B2 | Phosphorus electrolytic solution containing magnesium ions | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2020-12-08 | — | — | US | disclosed |
| US-10451967-B2 | Acid- and radical-generating agent and method for generating acid and radical | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2019-10-22 | — | — | US | disclosed |
| US-20190296396-A1 | PHOSPHORUS ELECTROLYTIC SOLUTION CONTAINING MAGNESIUM IONS | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2019-09-26 | — | — | US | disclosed |
| EP-3467931-A1 | PHOSPHORUS ELECTROLYTIC SOLUTION CONTAINING MAGNESIUM IONS | FUJIFILM Wako Pure Chemical Corporation (JP) | 2019-04-10 | — | — | EP | disclosed |
| US-20160342084-A1 | ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2016-11-24 | — | — | US | disclosed |
| EP-1678185-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-07-12 | — | — | EP | disclosed |
| WO-2005042542-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-05-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10862169-B2 | Phosphorus electrolytic solution containing magnesium ions | PEF1, RER1, AFF1 | ELANE 928/4885NFKB1 845/4885CA1 74/4885 |
| US-10451967-B2 | Acid- and radical-generating agent and method for generating acid and radical | CBR1, HAO2, CBR3 | ELANE 1630/4885NFKB1 2955/4885CA1 719/4885 |
| US-20160342084-A1 | ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL | CBR1, HAO2, CBR3 | ELANE 1630/4885NFKB1 2955/4885CA1 719/4885 |
| US-20190296396-A1 | PHOSPHORUS ELECTROLYTIC SOLUTION CONTAINING MAGNESIUM IONS | PEF1, RER1, AFF1 | ELANE 928/4885NFKB1 845/4885CA1 74/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.